News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
247 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (25384)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Deals
Teva Announces Completion of PARAGARD Divestiture to CooperSurgical
This transaction includes Teva’s manufacturing facility in Buffalo, NY, which produces PARAGARD exclusively.
November 1, 2017
·
6 min read
Business
e-Therapeutics Release: Appointment of Director
e-Therapeutics announces the appointment of Christine Soden as non-executive director, and the retirement of Brad Hoy who has served on the e-Therapeutics Board as a non-executive director for nine years.
November 1, 2017
·
1 min read
Mauna Kea Technologies Release: New Contact Study Analysis Demonstrates Cellvizio’s Ability to Improve the Management of Patients With Pancreatic Cysts
The UEGW meeting takes place from October 28 to November 1, 2017 in Barcelona, Spain, and is hosted by the United European Gastroenterology (UEG), a professional non-profit organization combining all the leading European societies concerned with digestive health
November 1, 2017
·
4 min read
BioMidwest
Greenlight Guru Extends Platform with New Product, Grow, to Streamline Postmarket Quality Processes
Greenlight Guru’s software can assist medical device companies after the launch of a device by connecting its entire quality ecosystem and advancing the success of high-quality devices already on the market.
November 1, 2017
·
3 min read
Business
Capricor Third Quarter 2017 Update Webcast and Conference Call Scheduled for Wednesday, November 8
Capricor will report third quarter 2017 financial results shortly after the NASDAQ market close on Wednesday, November 8, 2017.
November 1, 2017
·
3 min read
Business
Astellas Announces Leadership Changes in U.S. Health Systems Commercial Organization
Astellas today announced two senior-level changes in its U.S. Commercial organization within the company’s Health Systems business unit.
November 1, 2017
·
2 min read
Business
Nuvo Pharma Announces 2017 Third Quarter Results
Total revenue for the three months ended September 30, 2017 was $3M compared to $5.5M for the three months ended September 30, 2016.
November 1, 2017
·
17 min read
Business
CRH Medical Corporation Announces Results for the Three and Nine Months Ended September 30, 2017
CRH Medical, today announced financial and operating results for the three and nine months ended September 30, 2017.
November 1, 2017
·
31 min read
Drug Development
The New England Journal of Medicine Publishes First Phase III Study Results of SPINRAZA® for the Treatment of Spinal Muscular Atrophy
SPINRAZA demonstrated a favorable benefit-risk profile.
November 1, 2017
·
14 min read
Business
Akros Pharma and Medidata Commemorate 10-year Partnership With Platform Expansion Agreement
Medidata announced today that Akros Pharma has entered into an additional multi-year platform agreement, further expanding their 10-year old partnership to improve the efficiency and efficacy of their clinical trials.
November 1, 2017
·
2 min read
Previous
17 of 25
Next